Effect of trikatu compound in hypercholesteremia- a clinical study
Vinod Bihari Kumawat, Surendra Kumar Sharma, Uttam Kumar Sharma and 1 more
Environment Conservation Journal · 2015
doi:10.36953/ecj.2015.161209 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
A clinical trial was under taken to evaluate the efficacy of the drug Trikatu Compound in treatment of hypercholesteremia patients. The dose of the trial drug was fixed at 3 gram twice a day after meal with lukewarm water for group A. Group-B was on only Atorvastatin 20mg (hypolipidemic drug) and group-C was placebo. After 3 months of drug trial there was highly significant (p<0.001) result observed in group A. symptomatic relief was also reported by the patients. Also no adverse effects were reported by group A patients during the study. This study reveals that Trikatu Compound is useful in treatment of hypercholesteremia.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.